None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Healthy male and female whose age are 20 <= years old <65. (2) Subjects who are able to submit the written informed consents.
Exclusion criteria
Exclusion criteria: (1) Systolic pressure <90 mmHg (2) Subjects who are pregnant or lactating. (3) Subjects who donated over 200ml blood components or whole blood within 4 weeks (4) Male Subjects who donated over 400ml whole blood within 12 weeks (5) Female who donated over 400ml whole blood within 16 weeks (6) Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. (7) Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. (8) Subjects who are participating in other clinical studies, or who finished clinical study within 4 weeks. (9) a) Subjects with disease on heart, liver, kidney or the other organs complication. b) Subjects with a previous history of disease on circulatory organs c) Subjects who are contracting diabetes. d) Subjects with test food allergy (10) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum concentration and area under the curve of blood glucose levels. | — |
Countries
Japan
Contacts
Suntory Global Innovation Center Ltd. Research Institute